The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.
Saved in:
| Title: | The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. |
|---|---|
| Authors: | Borgan, Faith (AUTHOR), Beck, Katherine (AUTHOR), Butler, Emma (AUTHOR), McCutcheon, Robert (AUTHOR), Veronese, Mattia (AUTHOR), Vernon, Anthony (AUTHOR), Howes, Oliver D. (AUTHOR) |
| Source: | Psychopharmacology. Nov2019, Vol. 236 Issue 11, p3257-3270. 14p. 3 Graphs. |
| Subjects: | Bacopa monnieri, Meta-analysis, Memory, Spatial memory, Cycloserine, Cannabinoid receptors, Memory testing, Neural transmission |
| Abstract: | Rationale: While cannabis-based medicinal products have been shown to be effective for numerous neurological and psychiatric disorders, the evidence base regarding their adverse cognitive effects is poorly understood. The cannabinoid 1 receptor modulates memory performance via intracellular and extracellular mechanisms that alter synaptic transmission and plasticity. While previous literature has consistently shown that chronic cannabis users exhibit marked cognitive impairments, mixed findings have been reported in the context of placebo-controlled experimental trials. It is therefore unclear whether these compounds inherently alter cognitive processes or whether individuals who are genetically predisposed to use cannabis may have underlying cognitive deficits. Objective: We conducted a meta-analysis to investigate the effects of full and partial cannabinoid 1 receptor (CB1R) agonists, antagonists, and negative allosteric modulators on non-spatial and spatial memory. Methods: In accordance with the PRISMA guidelines, the EMBASE, MEDLINE, and PsycINFO databases were systematically searched for studies examining the effects of CB1R agonists, antagonists, and negative allosteric modulators on memory performance. Results: We systematically reviewed 195 studies investigating the effects of cannabinoid compounds on memory. In humans (N = 35 studies, comprising N = 782 subjects), delta-9-tetrahydrocannabinol (THC) (1.5–5 mg/kg) relative to placebo impaired performance on non-spatial memory tests, whereas only high THC doses (67 mg/kg) impaired spatial memory. Similarly, THC (0.2–4 mg/kg) significantly impaired visuospatial memory in monkeys and non-human primates (N = 8 studies, comprising N = 71 subjects). However, acute THC (0.002–10 mg/kg) had no effect on non-spatial (N = 6 studies, comprising 117 subjects; g = 1.72, 95% confidence interval (CI) − 0.18 to 3.63, p = 0.08) or spatial memory (9 studies, comprising 206 subjects; g = 0.75, 95% confidence interval (CI) − 1.09 to 2.58, p = 0.43). However, acute, full CB1R agonists significantly impaired non-spatial memory (N = 23 studies, 519 subjects; g = − 1.39, 95% CI − 2.72 to − 0.06, p = 0.03). By contrast, the chronic administration of CB1R agonists had no effect on non-spatial memory (N = 5 studies, comprising 146 subjects; g = − 0.05, 95% confidence interval (CI) − 1.32 to 1.22, p = 0.94). Moreover, the acute administration of CB1R antagonists had no effect on non-spatial memory in rodents (N = 9 studies, N = 149 subjects; g = 0.40, 95% CI − 0.11 to 0.92, p = 0.12). Conclusions: The acute administration of THC, partial CB1R agonist, significantly impaired non-spatial memory in humans, monkeys, and non-human primates but not rodents. However, full CB1R agonists significantly impaired non-spatial memory in a dose-dependent manner but CB1R antagonists had no effect on non-spatial memory in rodents. Moreover, chronic THC administration did not significantly impair spatial or non-spatial memory in rodents, and there is inconclusive evidence on this in humans. Our findings highlight species differences in the effects of cannabinoid compounds on memory. [ABSTRACT FROM AUTHOR] |
| Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 139478882 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Borgan%2C+Faith%22">Borgan, Faith</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beck%2C+Katherine%22">Beck, Katherine</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Butler%2C+Emma%22">Butler, Emma</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McCutcheon%2C+Robert%22">McCutcheon, Robert</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Veronese%2C+Mattia%22">Veronese, Mattia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vernon%2C+Anthony%22">Vernon, Anthony</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Howes%2C+Oliver+D%2E%22">Howes, Oliver D.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Psychopharmacology%22">Psychopharmacology</searchLink>. Nov2019, Vol. 236 Issue 11, p3257-3270. 14p. 3 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Bacopa+monnieri%22">Bacopa monnieri</searchLink><br /><searchLink fieldCode="DE" term="%22Meta-analysis%22">Meta-analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Memory%22">Memory</searchLink><br /><searchLink fieldCode="DE" term="%22Spatial+memory%22">Spatial memory</searchLink><br /><searchLink fieldCode="DE" term="%22Cycloserine%22">Cycloserine</searchLink><br /><searchLink fieldCode="DE" term="%22Cannabinoid+receptors%22">Cannabinoid receptors</searchLink><br /><searchLink fieldCode="DE" term="%22Memory+testing%22">Memory testing</searchLink><br /><searchLink fieldCode="DE" term="%22Neural+transmission%22">Neural transmission</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Rationale: While cannabis-based medicinal products have been shown to be effective for numerous neurological and psychiatric disorders, the evidence base regarding their adverse cognitive effects is poorly understood. The cannabinoid 1 receptor modulates memory performance via intracellular and extracellular mechanisms that alter synaptic transmission and plasticity. While previous literature has consistently shown that chronic cannabis users exhibit marked cognitive impairments, mixed findings have been reported in the context of placebo-controlled experimental trials. It is therefore unclear whether these compounds inherently alter cognitive processes or whether individuals who are genetically predisposed to use cannabis may have underlying cognitive deficits. Objective: We conducted a meta-analysis to investigate the effects of full and partial cannabinoid 1 receptor (CB1R) agonists, antagonists, and negative allosteric modulators on non-spatial and spatial memory. Methods: In accordance with the PRISMA guidelines, the EMBASE, MEDLINE, and PsycINFO databases were systematically searched for studies examining the effects of CB1R agonists, antagonists, and negative allosteric modulators on memory performance. Results: We systematically reviewed 195 studies investigating the effects of cannabinoid compounds on memory. In humans (N = 35 studies, comprising N = 782 subjects), delta-9-tetrahydrocannabinol (THC) (1.5–5 mg/kg) relative to placebo impaired performance on non-spatial memory tests, whereas only high THC doses (67 mg/kg) impaired spatial memory. Similarly, THC (0.2–4 mg/kg) significantly impaired visuospatial memory in monkeys and non-human primates (N = 8 studies, comprising N = 71 subjects). However, acute THC (0.002–10 mg/kg) had no effect on non-spatial (N = 6 studies, comprising 117 subjects; g = 1.72, 95% confidence interval (CI) − 0.18 to 3.63, p = 0.08) or spatial memory (9 studies, comprising 206 subjects; g = 0.75, 95% confidence interval (CI) − 1.09 to 2.58, p = 0.43). However, acute, full CB1R agonists significantly impaired non-spatial memory (N = 23 studies, 519 subjects; g = − 1.39, 95% CI − 2.72 to − 0.06, p = 0.03). By contrast, the chronic administration of CB1R agonists had no effect on non-spatial memory (N = 5 studies, comprising 146 subjects; g = − 0.05, 95% confidence interval (CI) − 1.32 to 1.22, p = 0.94). Moreover, the acute administration of CB1R antagonists had no effect on non-spatial memory in rodents (N = 9 studies, N = 149 subjects; g = 0.40, 95% CI − 0.11 to 0.92, p = 0.12). Conclusions: The acute administration of THC, partial CB1R agonist, significantly impaired non-spatial memory in humans, monkeys, and non-human primates but not rodents. However, full CB1R agonists significantly impaired non-spatial memory in a dose-dependent manner but CB1R antagonists had no effect on non-spatial memory in rodents. Moreover, chronic THC administration did not significantly impair spatial or non-spatial memory in rodents, and there is inconclusive evidence on this in humans. Our findings highlight species differences in the effects of cannabinoid compounds on memory. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=139478882 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00213-019-05283-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 3257 Subjects: – SubjectFull: Bacopa monnieri Type: general – SubjectFull: Meta-analysis Type: general – SubjectFull: Memory Type: general – SubjectFull: Spatial memory Type: general – SubjectFull: Cycloserine Type: general – SubjectFull: Cannabinoid receptors Type: general – SubjectFull: Memory testing Type: general – SubjectFull: Neural transmission Type: general Titles: – TitleFull: The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Borgan, Faith – PersonEntity: Name: NameFull: Beck, Katherine – PersonEntity: Name: NameFull: Butler, Emma – PersonEntity: Name: NameFull: McCutcheon, Robert – PersonEntity: Name: NameFull: Veronese, Mattia – PersonEntity: Name: NameFull: Vernon, Anthony – PersonEntity: Name: NameFull: Howes, Oliver D. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 00333158 Numbering: – Type: volume Value: 236 – Type: issue Value: 11 Titles: – TitleFull: Psychopharmacology Type: main |
| ResultId | 1 |